Erste Asset Management GmbH Invests $5.60 Million in The Clorox Company $CLX

Erste Asset Management GmbH purchased a new position in The Clorox Company (NYSE:CLXFree Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 56,400 shares of the company’s stock, valued at approximately $5,600,000.

Other large investors have also recently made changes to their positions in the company. Center for Financial Planning Inc. bought a new stake in shares of Clorox in the third quarter worth approximately $25,000. Vermillion & White Wealth Management Group LLC bought a new stake in shares of Clorox in the third quarter worth approximately $25,000. Darwin Wealth Management LLC bought a new stake in shares of Clorox in the second quarter worth approximately $29,000. Ameriflex Group Inc. grew its stake in shares of Clorox by 1,436.8% in the third quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock worth $36,000 after acquiring an additional 273 shares during the period. Finally, Vision Financial Markets LLC grew its stake in shares of Clorox by 166.7% in the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after acquiring an additional 200 shares during the period. 78.53% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on CLX shares. JPMorgan Chase & Co. dropped their price objective on shares of Clorox from $99.00 to $95.00 and set an “underweight” rating on the stock in a report on Friday, May 1st. Weiss Ratings raised shares of Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, April 13th. Wells Fargo & Company dropped their price objective on shares of Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a report on Monday, May 18th. UBS Group dropped their price objective on shares of Clorox from $110.00 to $96.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. Finally, The Goldman Sachs Group reissued a “sell” rating and issued a $83.00 price objective on shares of Clorox in a report on Friday, May 1st. One equities research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have given a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Reduce” and an average target price of $103.40.

Check Out Our Latest Report on CLX

Insiders Place Their Bets

In other Clorox news, Director Pierre R. Breber purchased 5,000 shares of the firm’s stock in a transaction on Tuesday, May 5th. The shares were acquired at an average cost of $85.82 per share, with a total value of $429,100.00. Following the completion of the acquisition, the director directly owned 18,000 shares in the company, valued at $1,544,760. The trade was a 38.46% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.63% of the stock is owned by corporate insiders.

Clorox Stock Performance

CLX opened at $98.54 on Wednesday. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03. The Clorox Company has a 12-month low of $84.70 and a 12-month high of $132.03. The company has a market cap of $11.92 billion, a price-to-earnings ratio of 16.00, a PEG ratio of 0.49 and a beta of 0.56. The company’s 50 day moving average is $96.74 and its 200 day moving average is $105.31.

Clorox (NYSE:CLXGet Free Report) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The business had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the previous year, the firm earned $1.45 earnings per share. The company’s revenue for the quarter was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, equities research analysts predict that The Clorox Company will post 5.61 EPS for the current year.

Clorox Profile

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Featured Stories

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.